Table 1.

Pre-treatment characteristics.

	n=131	%
HBeAg positivity	28	21.4
HBV-DNA > 2x107IU/ml	21	16
ALT >40IU/ml	66	50.4
Treatment-experience (Previous treatment) LAM IFN + LAM Peg-IFN Peg-IFN + LAM	43 18 12 10 3	32.8 13.7 9.2 7.6 2.3
Presence of liver biopsy Fibrosis stage ≥2 Cirrhosis detected	109 88 2	83.2 67.2 1.5
Presence of cirrhosis	12	9.2
Serum creatinine >1.1 mg/dl	4	3.1